Wednesday, November 2, 2016

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, informs you:


Fenugreek seeds (Trigonella foenum graecum) are known to exhibit potent hypoglycaemic activities. The mechanism of action remains unclear, but recent studies suggest that furostanolic saponins may be involved. In order to clarify the effects of furostanolic saponins, the effects of a proprietary fenugreek extract (FenufuroTM) (40% furostanolic sanonins) have been examined in subjects with type 2 diabetes.


This study was randomized, double-blinded and placebo-controlled. 154 subjects have received a placebo or FenfuroTM (500 mg twice daily) for 90 days. The supplementation has reduced both fasting and post-prandial plasma sugar levels. HbA1c levels has been reduced in both groups. Moreover, fasting and post-prandial C-peptide levels have been increased in the supplemented group, while no change has been observed in the placebo group. Moreover, more subjects in the supplemented group reduced their anti-diabetic therapy in comparison to the placebo group (48.8% vs. 18.05%). Finally, no significant adverse event were observed. This study confirms therefore the beneficial effects of fenugreek seed extracts, and suggests that furostanolic saponins may be involved in this anti-diabetic activity.


Verma N, Usman K, Patel N, Jain A, Dhakre S, Swaroop A, Bagchi M, Kumar P, Preuss HG, Bagchi D. A multicenter clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum) extract (Fenfuro™) in patients with type 2 diabetes. Food Nutr Res. 2016 Oct 11;60:32382.


This information has been sourced by NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders.

This collaborative and complete tool contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…


More information on

Contact our Scientific & Regulatory experts at NUTRAVERIS, +33 2 96 76 54 87

Leave a Reply